Adlon Therapeutics L.P. Announces FDA Approval for Adhansia XR™ (methylphenidate HCl) Extended-Release Capsules CII for the Treatment of ADHD Guest UserMarch 11, 2019 Facebook0 Twitter LinkedIn0 0 Likes